Calixarenes (CAs), representing the third generation of supramolecular hosts and one of the
most widely studied macrocyclic scaffolds, offer (almost) unlimited structure and application …

Cancer is the second leading cause of death affecting nearly one in two people, and the
appearance of new cases is projected to rise by> 70% by 2030. To effectively combat the …

Macrocyclic amphiphiles as an emerging family of artificial amphiphiles have gained
considerable attention in recent years on account of their fascinating recognition and …

Supramolecular luminescent nano‐assemblies for cell imaging have recently attracted
increasing interest, not only because of their outstanding photophysical properties, but also …

A new series of p-tertbutylcalix [4] arenes integrated with isomer trifluoromethyl anilines has
been designed as potential anticancer agents. The integration of trifluoromethyl anilines to p …

Despite the anticancer potential of natural products (NPs), their limited bioavailability
necessitates laborious derivatization or covalent conjugation to delivery vehicles. To …

The unique conformational properties, functionality, low toxicity, and low cost make
calixarene-based compounds a valuable candidate against cancer. The aim of the present …

The alkylating agent temozolomide (TMZ) is the first-line chemotherapeutic for glioblastoma
(GBM), a common and aggressive primary brain tumor in adults. However, its poor stability …

The therapy of various diseases by the drugs entrapped in calixarene derivatives is gaining
attraction of researchers nowadays. Calixarenes are macrocyclic nano-baskets which …

Cancer is one of the leading causes of death worldwide, and the limited success of currently
used anticancer drugs is a driving force for the search for new compounds with anticancer …